(±)-Pomalidomide-d3 (phthalimide-4,5,6-d3)

(±)-Pomalidomide-d3 (phthalimide-4,5,6-d3) is a deuterated form of Pomalidomide, a drug used in the treatment of multiple myeloma and other blood disorders. The deuterated form is used in research and development studies, as it allows for tracking of the drug's movement and activity within the body. Chemically, (±)-Pomalidomide-d3 is a small molecule inhibitor that works by targeting and inhibiting the production of certain proteins involved in the growth and survival of cancer cells. The drug is believed to enhance the body's immune response against cancer cells, leading to their destruction. The usage of (±)-Pomalidomide-d3 is mainly in the field of pharmacology and drug development. Researchers use this drug to study its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion. By studying how the drug is metabolized and eliminated from the body, researchers can optimize dosing and improve drug efficacy. In summary, (±)-Pomalidomide-d3 is a deuterated form of Pomalidomide used in research and development studies. Its chemical properties make it a valuable tool in the study of pharmacokinetics and drug development. The drug's ability to inhibit protein production and enhance the immune response against cancer cells make it a promising treatment option for multiple myeloma and other blood disorders.